Stainless Steel Powder Market worth $1.04 billion by 2030 – Exclusive Report by MarketsandMarkets™

According toMarketsandMarkets, 'Stainless Steel Powder Marketby Type (Austenitic, Martensitic, Duplex, Ferritic, Precipitation-Hardening), Manufacturing Process, Application (Powder Metallurgy, Metal Injection Molding, Additive Manufacturing, Other Processes), End-use Industry, and Region – Global Forecast to 2030', the global stainless steel powder market is expected to reach USD 1.04 billion by 2030 from USD 0.85 billion in 2025, at […]

HORMEL FOODS REPORTS FOURTH QUARTER AND FULL-YEAR FISCAL 2025 RESULTS

Top-Line Strength Continues; Company Sees Clear Path for Profitable Growth in Fiscal 2026 Hormel Foods Corporation (NYSE: HRL), a Fortune 500 global branded food company, today reported fourth quarter and full-year fiscal 2025 results. All comparisons are to the same period of fiscal 2024 unless otherwise noted. https://mma.prnewswire.com/media/2774643/Hormel_Foods_Logo.jpg EXECUTIVE SUMMARY – FISCAL 2025 — Net

Correcting and Replacing Original Release From November 28, 2025: Laser Photonics Announces Receipt of Non-Compliance Letter from Nasdaq

ORLANDO, FL / ACCESS Newswire / December 4, 2025 / This release is to clarify in the title that the Company has not received a delisting notice. Laser Photonics Corporation (LPC) (NASDAQ:LASE), a leading global industrial developer of CleanTech Laser Systems for laser cleaning and other applications, today announced that on November 20, 2025, it

Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics

(NASDAQ:CBIO),(HKSE:6990.HK),(HKSE:6990),(Shenzhen:002422),(Shenzhen:002422.SZ), Companies to advance CR-001, a PD-1 x VEGF bispecific antibody, and SKB105, an integrin beta-6-directed antibody-drug conjugate (ADC), in global markets and China Collaboration designed to accelerate and expand the development of synergistic combinations with CR-001 and ADCs, including SKB105 CR-001 and SKB105 on track to enter Phase 1/2 monotherapy clinical trials in Q1

Merakris Therapeutics Announces Completion of Type C Meeting with FDA – Alignment on MTX-001 Biologic Drug Development Pathway

RESEARCH TRIANGLE PARK, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) — Merakris Therapeutics, a clinical-stage biopharmaceutical company focused on advancing innovative biologic drug therapies for chronic wounds, announced that it has successfully completed a Type C meeting with the U.S. Food and Drug Administration (FDA). This results in meaningful regulatory alignment for clinical efficacy expectations, potency

Ducommun Incorporated named BAE Systems Supplier of the Year for Vertical Launch Systems at Seventh Annual ‘Partner2Win’ Supplier Symposium

(NYSE:DCO), COSTA MESA, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) — Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) received Vertical Launch Systems Supplier of the Year award at BAE Systems' 'Partner2Win' suppler symposium, recognizing its exceptional performance and commitment to operational excellence this year. Ducommun's contributions to supply chain success helped BAE Systems ensure quality,

Kraken Robotics Appoints Kim Butler to Board of Directors and Hires Bernard Mills as Executive Vice President, Defence

(TSX-V:PNG),(OTC US:KRKNF),(Other OTC:KRKNF), ST. JOHN'S, Newfoundland and Labrador, Dec. 04, 2025 (GLOBE NEWSWIRE) — Kraken Robotics Inc. (“Kraken” or the “Company“) (TSX-V: PNG, OTCQB: KRKNF) is pleased to announce two strategic additions to its leadership team: the appointment of Kim Butler, CPA, ICD.D, to its Board of Directors and the hiring of Bernard Mills as

Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics

Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics GlobeNewswire December 04, 2025 Companies to advance CR-001, a PD-1 x VEGF bispecific antibody, and SKB105, an integrin beta-6-directed antibody-drug conjugate (ADC), in global markets and China Collaboration designed to accelerate and expand the development of synergistic combinations with CR-001 and

Merakris Therapeutics Announces Completion of Type C Meeting with FDA – Alignment on MTX-001 Biologic Drug Development Pathway

Merakris Therapeutics Announces Completion of Type C Meeting with FDA – Alignment on MTX-001 Biologic Drug Development Pathway GlobeNewswire December 04, 2025 RESEARCH TRIANGLE PARK, N.C., Dec. 04, 2025 (GLOBE NEWSWIRE) — Merakris Therapeutics, a clinical-stage biopharmaceutical company focused on advancing innovative biologic drug therapies for chronic wounds, announced that it has successfully completed a

Ducommun Incorporated named BAE Systems Supplier of the Year for Vertical Launch Systems at Seventh Annual ‘Partner2Win’ Supplier Symposium

Ducommun Incorporated named BAE Systems Supplier of the Year for Vertical Launch Systems at Seventh Annual 'Partner2Win' Supplier Symposium GlobeNewswire December 04, 2025 COSTA MESA, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) — Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) received Vertical Launch Systems Supplier of the Year award at BAE Systems' 'Partner2Win' suppler symposium,

Scroll to Top